Corrigendum to "Comprehensive characterization of immune landscape of Indian and Western triple negative breast cancers": Translational Oncology 2022 Nov; 25:101511.

Saved in:
Bibliographic Details
Title: Corrigendum to "Comprehensive characterization of immune landscape of Indian and Western triple negative breast cancers": Translational Oncology 2022 Nov; 25:101511.
Authors: Korlimarla A; St. John's Research Institute, St. John's National Academy of Health Sciences, Bangalore, India; Sri Shankara Cancer Hospital and Research Centre, Bangalore, India., Hari PS; St. John's Research Institute, St. John's National Academy of Health Sciences, Bangalore, India; Sri Shankara Cancer Hospital and Research Centre, Bangalore, India; Division of Molecular Pathology, The Institute of Cancer Research, London, UK., Prabhu J; St. John's Research Institute, St. John's National Academy of Health Sciences, Bangalore, India., Ragulan C; Division of Molecular Pathology, The Institute of Cancer Research, London, UK., Patil Y; Division of Molecular Pathology, The Institute of Cancer Research, London, UK., Snijesh VP; St. John's Research Institute, St. John's National Academy of Health Sciences, Bangalore, India., Desai K; Division of Molecular Pathology, The Institute of Cancer Research, London, UK., Mathews A; MOSC Medical College, Kolenchery, Kerala, India., Appachu S; Sri Shankara Cancer Hospital and Research Centre, Bangalore, India., Diwakar RB; Sri Shankara Cancer Hospital and Research Centre, Bangalore, India., Srinath BS; Sri Shankara Cancer Hospital and Research Centre, Bangalore, India., Melcher A; Centre for Translational Immunotherapy, Division of Radiotherapy and Imaging, The Institute of Cancer Research, London, UK., Cheang M; Clinical Trials and Statistical Unit, The Institute of Cancer Research, London, UK., Sadanandam A; Division of Molecular Pathology, The Institute of Cancer Research, London, UK; Centre for Translational Immunotherapy, Division of Radiotherapy and Imaging, The Institute of Cancer Research, London, UK; Centre for Global Oncology, Division of Molecular Pathology, The Institute of Cancer Research, London, UK. Electronic address: Anguraj.sadanandam@icr.ac.uk.
Source: Translational oncology [Transl Oncol] 2023 Jan; Vol. 27, pp. 101574. Date of Electronic Publication: 2022 Nov 03.
Publication Type: Published Erratum
Journal Info: Publisher: Neoplasia Press Country of Publication: United States NLM ID: 101472619 Publication Model: Print-Electronic Cited Medium: Print ISSN: 1936-5233 (Print) Linking ISSN: 19365233 NLM ISO Abbreviation: Transl Oncol Subsets: PubMed not MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:1936-5233
DOI:10.1016/j.tranon.2022.101574